top of page

Vision, Mission, Values

Find out about us by reading what others are saying about us.

You can also find out on Team RNAscence and our journey.

What's New?

Find out about us by reading what others are saying about us.

You can also find out on Team RNAscence and our journey.

TIDES Asia: Oligonucleotide and Peptide Therapeutics

19-22 March 2024

Hello Kyoto! Our co-founder and technology expert, Prof. Timothy Tan presented to a global conference attended by experts from both biopharmaceutical companies and academia, coming from around the world.


He presented on the topic: "Clinically Effective Scar Treatment via a siRNA Transdermal Gene Silencing Technology: From Bench to Bedside and Beyond".

We are heartened and thankful that the potential of our technology is shared to a wider audience and look forward to future collaborations.

The potential of RNA therapeutics in dermatology

2 February 2024

We are excited to share that an article written by our co-founders and co-inventors is accepted by the Annals Singapore - Academy of Medicine. 

In this commentary, our experts share the potential of RNA therapeutics in reaching undruggable targets with minimal off-target effects and high specificity for dermatological conditions.

Visit the link to access our open access article.

European Academy of Dermatology and Venereology Congress

11-14 October 2023

Hallo Berlin! Our research work at the National Skin Centre led by Prof Timothy Tan and Prof Tey Hong Liang is highlighted and shared at the EADV Congress in Berlin. We are pleased to reach out to a broader audience, and share our technology in scar prevention compared to silicon gel sheets.

The science behind Renectin and the clinical trial at the National Skin Centre was presented and shared with other dermatologists and medical professionals.

Singapore Health and Biomedical Congress 2023

12-13 October 2023

As one of the spin-offs from the National Healthcare Group (National Skin Centre), we are glad to be able to share our technology and showcase our progress to potential collaborators. The SHBC is the flagship programme of the National Healthcare Group and this event has exposed us to clinicians, researchers and the scientific community. Our Clinical Advisor and co-inventor, Prof Tey shared his findings with the medical community during this event. In one of the panel discussions, our CEO, Chan Wen Kiat was invited alongside our co-inventor, Prof Tey and two other start-up CEOs to share on the medtech space. We are hopeful for future partnerships.

NTUitive Roadshow 2023

12 October 2023

As one of the spin-offs from Nanyang Technological University, we are proud to be invited to showcase our technology and company to potential investors, collaborators and partners. Our first event since the launch of Renectin Antiscar back in March this year, our journey back to NTU has brought back memories of our earlier days as a young company. We are glad to be given the opportunity to pitch to potential investors on the event day itself.

Society of Cosmetic Scientists (Singapore) Supplier's Day

13-15 Sep 2023

We are thankful to be invited to host a booth at the Society of Cosmetic Scientists (Singapore) Supplier's Day. Prof Tim conducted a seminar session to share on our technology, while on the exhibition day, we managed to interact with other businesses and potential partners.

co11ab Novena Official Opening

22 Aug 2023

co11ab Novena is the first of its kind, medtech incubator space located in the midst of a healthcare precinct in Singapore, supported by a tripartite system consisting of Nanyang Technological University, Agency for Science, Technology and Research as well as the National Healthcare Group.

We are proud to be amongst their maiden batch of start-ups incubating here and we are pleased to be part of their opening ceremony and launch day, graced by Senior Minister of State, Dr. Janil Puthucheary. 

Prof Joseph Sung, the Dean of Lee Kong Chian School of Medicine, visited our booth, hosted by Prof Timothy Tan and Prof Tey Hong Liang, as well as our team members. In this proud moment, we were also interviewed by members of the press and are truly grateful for their sharing. Through this moment, we were featured in The Straits Times and Zaobao.


We would also like to extend our appreciation to clinicians who have reached out to us, as well as the general public who have made purchases directly from our website, after our company has made the news.

25th World Congress of Dermatology

3-8 July 2023

We are honoured and thankful to be given a feature space at the 25th World Congress of Dermatology, courtesy of the National Skin Centre. This event is the largest dermatologist event in the world and has attracted thousands of participants globally. Through the event, we have obtained our first clinician adopters from the Philippines and Hong Kong.

Media description:

The NSC exhibition space showcasing our technology. Also, Dr Tan-Torres from the Philippines with our team members. Our co-inventor, Dr Tey Hong Liang also gave an interview.

Exploration of Skin Innovations and Technology

28 June 2023

We are pleased to support co11ab Novena's seminar on the 'Exploration of Skin Innovations and Technology'. Our speakers, Prof. Timothy Tan and Prof. Tey Hong Liang were present to share on the latest innovations in the skin health space and we are thankful for the opportunity.

Prof Tim shared on the latest in scar prevention technology, while Prof Tey shared on the innovations developed by the National Healthcare Group.

Nassim Plastic Surgery x RNAscence Biotech

27 April 2023

We are pleased to announce that Nassim Plastic Surgery will be offering Renectin Antiscar to patients as part of their post-surgery recovery procedure. Led by Dr Janna Joethy, Nassim Plastic Surgery has glowing patient reviews and offers excellent service in the words of his own patients.


As an artist and scientist looking for the best scarless outcomes for his patients, Dr Janna first contacted us after learning of our scientific discoveries. This was months before Renectin Antiscar was conceptualised and created. His sincerity, candid opinions and warmth have shaped us in designing Renectin Antiscar and we are proud to be associated with him.


Visit or click on the logo below to find out more!

CNA938 Health Matters with Daniel Martin

21 April 2023

Catch the podcast of Timothy Tan on Health Matters interview with CNA938's Daniel Martin.

Tim Tan x Daniel Martin CNA938

Lee Kong Chian School of Medicine: The Art and Science of Medicine Festival 2023

18 March 2023

Our team had the privilege to host a booth at the Lee Kong Chian School of Medicine (LKCMedicine) the Art and Science of Medicine Festival 2023. With the event based in HDB Hub, Toa Payoh, this is the first time our company and Renectin Antiscar is introduced to the general public. In this event, we showcased how skin health research in the academic setting could translate into an industrial collaboration and the birth of Renectin Antiscar. We are thankful for the organisers in setting up the venue for us and for the public who visited our booth. We also would like to record our thanks to Minister Ng Eng Hen for visiting us.

Skin Health Innovation booth at the LKCMedicine event. From left to right: Chun Yong Yao (Research Fellow,- NTU, co-founder and co-inventor, RNAscence Biotech Pte. Ltd.), Diana Chor (General Manager, RNAscence Biotech Pte. Ltd.), Minister Ng Eng Hen (Singapore Minister for Defence), Chan Wen Kiat (co-founder and CEO, RNAscence Biotech Pte. Ltd.), and Tey Hong Liang (Assoc. Prof. - LKCMedicine, academic collaborator and co-inventor).

Photo credit: Centre for Medical Technologies and Innovations post dated 21 March 2023.

The following is the post from the Centre for Medical Technologies and Innovations (CMTi) with original source here. Thank you once again for the strong support given to Singapore start-ups.

NTU Innovation and Entrepreneurship Launch Event 

16 March 2023

Our team hosted a booth for the NTU Innovation and Entrepreneurship (NTU I&E) Launch event on 16 March 2023. It was a memorable day for us as it is the same day where Renectin Antiscar is officially available for pre-order to the public and introduced to the NTU community. Thank you NTU for allowing us to showcase our company for the event and a further thank you to Minister Low Yen Ling for visiting our booth.

Team RNAscence Biotech booth at the NTU I&E Launch event. From left to right: Chan Wen Kiat (co-founder, CEO), Timothy Tan (Assoc. Prof. - NTU, co-founder, co-inventor), Minister Low Yen Ling (Singapore Minister of State for Trade and Industry), Chun Yong Yao (Research Fellow - NTU, co-founder, co-inventor), and Diana Chor (General Manager).

Photo credit: NTU Facebook post dated 17 March 2023.

The following is an excerpt from an NTU Press Release and also picked up by EurekAlert! as reported on 16 March 2023.


Another start-up company is RNAscence Biotech, co-founded by two NTU professors, a research fellow and an NTU PhD student. Together, they developed a skin patch made from hundreds of bio-dissolvable microneedles that deliver RNA- based active nanoparticles that can significantly reduce scar formation.


The anti-scar technology was developed by Associate Professor Timothy Tan and Dr Chun Yong Yao from the School of Chemistry, Chemical Engineering and Biotechnology, and Associate Professor Tey Hong Liang from the Lee Kong Chian School of Medicine. Clinical trial results so far showed that the patch led to a 79 per cent reduction in scar volume after 60 days. Seven in 10 patients also had better outcomes than the current standard-of-care.



bottom of page